New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
07:06 EDTTBIOTransgenomic Inc announces issuance of U.S. patent for ICE COLD-PCR
Transgenomic announced that the U.S. Patent and Trademark Office has issued a new patent related to its licensed ICE COLD-PCR technology. The patent, titled “Full cold-PCR enrichment with reference blocking sequence”, was assigned U.S. Patent No. 8,623,603 and is set to expire in 2031. The new U.S. patent extends the scope and longevity of the COLD-PCR intellectual property portfolio. The '603 patent covers ICE COLD-PCR methods for enriching low abundance alleles in nucleic acid samples. It is directed in particular to the use of an excess amount of reference blocking sequence in an amplification reaction mixture in order to improve the enrichment efficiency, and reduce cycle time, of full COLD-PCR.
News For TBIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
07:11 EDTTBIOTransgenomic launches ICE-COLD PCR service in biomarket identification business
Transgenomic announced that its groundbreaking Multiplexed ICE COLD PCR technology is now available to pharmaceutical and biotechnology customers of the company’s Biomarker Identification business unit. MX-ICP is an ultra-high sensitivity DNA amplification technology that allows the detection of multiple mutations in multiple genes from any sample, either from a tumor biopsy or from liquids such as blood or urine. MX-ICP is validated and available for use on all sequencing platforms.
April 15, 2015
16:10 EDTTBIOTransgenomic reports Q4 EPS (77c), one estimate (56c)
Reports Q4 revenue $7.7M, one estimate $6.11M.
08:26 EDTTBIOTransgenomic to hold a business news update conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use